Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and signaling restricted access to the study page.SummaryDifference17%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe status text changed from 'No Results Posted' to 'Results Submitted', indicating that results data have been submitted for the trial and are moving toward public posting.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6. This reflects a backend/UI software update and does not change study content or data on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5. This indicates a minor site update and does not affect the study information.SummaryDifference0.1%

- Check65 days agoChange DetectedA new site revision tag v3.6.4 has been added, replacing the previous v3.6.3. This represents a minor internal update to the page and does not modify the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a software/template update. This change does not affect the study details or results shown on the page.SummaryDifference0.1%

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.